Since then, somatic SLC35A2 variants have been increasingly identified in drug‐resistant focal epilepsy, early epileptic encephalopathy, and epilepsy with mild malformations of cortical development with oligodendroglial hyperplasia (MOGHE) [50, 51, 52]. Here, SLC35A2 is linked to epilepsy.